Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Priya Shankarappa

3PUBLICATIONS

38CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Nov 02, 2022

The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models.

Katie E Hebron, Xiaolin Wan, Jacob S Roth

|Sep 15, 2021

Adenosine A2A Receptor Activation Enhances Blood-Tumor Barrier Permeability in a Rodent Glioma Model.

Amélie Vézina, Monica Manglani, DreeAnna Morris

|Sep 18, 2020

Efficacy, Tolerability, and Pharmacokinetics of Combined Targeted MEK and Dual mTORC1/2 Inhibition in a Preclinical Model of Mucosal Melanoma.

Bih-Rong Wei, Shelley B Hoover, Cody J Peer

Pageof 1

Frequent Collaborators

3 joint publications

Cody J Peer

3 joint publications

William D Figg

1 joint publications

Howard Yang

1 joint publications

DreeAnna Morris

1 joint publications

Matthew McCord

1 joint publications

Mark R Gilbert

1 joint publications

Dorian B McGavern

1 joint publications

Katie E Hebron

1 joint publications

Xiaolin Wan

1 joint publications

Jacob S Roth

Frequent Collaborators

3 joint publications

Cody J Peer

3 joint publications

William D Figg

1 joint publications

Howard Yang

1 joint publications

DreeAnna Morris

Top Related Videos

<i>Ex Vivo</i> Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease

<i>Ex Vivo</i> Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease

Published on : Mar 29, 2024

Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics

Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics

Published on : Nov 30, 2012

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

See more related videos

Top Related Videos

<i>Ex Vivo</i> Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease

<i>Ex Vivo</i> Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease

Published on : Mar 29, 2024

Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics

Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics

Published on : Nov 30, 2012

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

See more related videos